Pretreatment plasma fibrinogen level correlates with tumor progression and metastasis in patients with squamous cell carcinoma of the esophagus

Hiroya Takeuchi, Shunji Ikeuchi, Yuukou Kitagawa, Atsushi Shimada, Takashi Oishi, Yoh Isobe, Kiyoshi Kubochi, Masaki Kitajima, Sumio Matsumoto

Research output: Contribution to journalArticle

91 Citations (Scopus)

Abstract

Background: Hypercoagulation has been reported to be associated with tumor progression and a poor prognosis in various carcinomas. In this study, we examined fibrinogen levels in pretreated patients with esophageal squamous cell carcinoma (ESCC) and assessed its correlation with clinicopathological factors and prognosis in patients with ESCC. Methods: Pretreatment fibrinogen levels were examined prior to surgery or other treatments (e.g. endoscopic mucosal resection and chemoradiotherapy [CRT]) in 105 patients with primary ESCC. We investigated the association of fibrinogen levels with clinicopathological background factors and the survival of ESCC patients. Results: The plasma fibrinogen concentration (PFC) ranged from 209.4 to 781.6 mg/dL. Pretreatment PFC correlated significantly with the depth of invasion (T factor). There also existed a significant correlation between higher fibrinogen levels and lymph node metastasis (N factor) and distant organ metastasis. Patients with a higher fibrinogen level experienced a significantly worse overall survival (P = 0.006). Fibrinogen levels strongly correlated with platelet counts, white blood cell counts and tumor length. Pretreatment PFC were observed to have a significant correlation with CRT responsiveness in ESCC patients in stages II and III (P = 0.005). Conclusion: This study revealed that higher levels of fibrinogen correlated with tumor progression, metastasis and poor responsiveness to CRT in ESCC patients.

Original languageEnglish
Pages (from-to)2222-2227
Number of pages6
JournalJournal of Gastroenterology and Hepatology (Australia)
Volume22
Issue number12
DOIs
Publication statusPublished - 2007

Fingerprint

Fibrinogen
Esophagus
Squamous Cell Carcinoma
Neoplasm Metastasis
Neoplasms
Chemoradiotherapy
Survival
Platelet Count
Leukocyte Count
Esophageal Squamous Cell Carcinoma
Lymph Nodes
Carcinoma

Keywords

  • Chemoradiotherapy
  • Esophageal cancer
  • Fibrinogen
  • Metastasis
  • Survival

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Pretreatment plasma fibrinogen level correlates with tumor progression and metastasis in patients with squamous cell carcinoma of the esophagus. / Takeuchi, Hiroya; Ikeuchi, Shunji; Kitagawa, Yuukou; Shimada, Atsushi; Oishi, Takashi; Isobe, Yoh; Kubochi, Kiyoshi; Kitajima, Masaki; Matsumoto, Sumio.

In: Journal of Gastroenterology and Hepatology (Australia), Vol. 22, No. 12, 2007, p. 2222-2227.

Research output: Contribution to journalArticle

Takeuchi, Hiroya ; Ikeuchi, Shunji ; Kitagawa, Yuukou ; Shimada, Atsushi ; Oishi, Takashi ; Isobe, Yoh ; Kubochi, Kiyoshi ; Kitajima, Masaki ; Matsumoto, Sumio. / Pretreatment plasma fibrinogen level correlates with tumor progression and metastasis in patients with squamous cell carcinoma of the esophagus. In: Journal of Gastroenterology and Hepatology (Australia). 2007 ; Vol. 22, No. 12. pp. 2222-2227.
@article{1c0dc316c8ea4341bea9e580fd2e30c0,
title = "Pretreatment plasma fibrinogen level correlates with tumor progression and metastasis in patients with squamous cell carcinoma of the esophagus",
abstract = "Background: Hypercoagulation has been reported to be associated with tumor progression and a poor prognosis in various carcinomas. In this study, we examined fibrinogen levels in pretreated patients with esophageal squamous cell carcinoma (ESCC) and assessed its correlation with clinicopathological factors and prognosis in patients with ESCC. Methods: Pretreatment fibrinogen levels were examined prior to surgery or other treatments (e.g. endoscopic mucosal resection and chemoradiotherapy [CRT]) in 105 patients with primary ESCC. We investigated the association of fibrinogen levels with clinicopathological background factors and the survival of ESCC patients. Results: The plasma fibrinogen concentration (PFC) ranged from 209.4 to 781.6 mg/dL. Pretreatment PFC correlated significantly with the depth of invasion (T factor). There also existed a significant correlation between higher fibrinogen levels and lymph node metastasis (N factor) and distant organ metastasis. Patients with a higher fibrinogen level experienced a significantly worse overall survival (P = 0.006). Fibrinogen levels strongly correlated with platelet counts, white blood cell counts and tumor length. Pretreatment PFC were observed to have a significant correlation with CRT responsiveness in ESCC patients in stages II and III (P = 0.005). Conclusion: This study revealed that higher levels of fibrinogen correlated with tumor progression, metastasis and poor responsiveness to CRT in ESCC patients.",
keywords = "Chemoradiotherapy, Esophageal cancer, Fibrinogen, Metastasis, Survival",
author = "Hiroya Takeuchi and Shunji Ikeuchi and Yuukou Kitagawa and Atsushi Shimada and Takashi Oishi and Yoh Isobe and Kiyoshi Kubochi and Masaki Kitajima and Sumio Matsumoto",
year = "2007",
doi = "10.1111/j.1440-1746.2006.04736.x",
language = "English",
volume = "22",
pages = "2222--2227",
journal = "Journal of Gastroenterology and Hepatology (Australia)",
issn = "0815-9319",
publisher = "Wiley-Blackwell",
number = "12",

}

TY - JOUR

T1 - Pretreatment plasma fibrinogen level correlates with tumor progression and metastasis in patients with squamous cell carcinoma of the esophagus

AU - Takeuchi, Hiroya

AU - Ikeuchi, Shunji

AU - Kitagawa, Yuukou

AU - Shimada, Atsushi

AU - Oishi, Takashi

AU - Isobe, Yoh

AU - Kubochi, Kiyoshi

AU - Kitajima, Masaki

AU - Matsumoto, Sumio

PY - 2007

Y1 - 2007

N2 - Background: Hypercoagulation has been reported to be associated with tumor progression and a poor prognosis in various carcinomas. In this study, we examined fibrinogen levels in pretreated patients with esophageal squamous cell carcinoma (ESCC) and assessed its correlation with clinicopathological factors and prognosis in patients with ESCC. Methods: Pretreatment fibrinogen levels were examined prior to surgery or other treatments (e.g. endoscopic mucosal resection and chemoradiotherapy [CRT]) in 105 patients with primary ESCC. We investigated the association of fibrinogen levels with clinicopathological background factors and the survival of ESCC patients. Results: The plasma fibrinogen concentration (PFC) ranged from 209.4 to 781.6 mg/dL. Pretreatment PFC correlated significantly with the depth of invasion (T factor). There also existed a significant correlation between higher fibrinogen levels and lymph node metastasis (N factor) and distant organ metastasis. Patients with a higher fibrinogen level experienced a significantly worse overall survival (P = 0.006). Fibrinogen levels strongly correlated with platelet counts, white blood cell counts and tumor length. Pretreatment PFC were observed to have a significant correlation with CRT responsiveness in ESCC patients in stages II and III (P = 0.005). Conclusion: This study revealed that higher levels of fibrinogen correlated with tumor progression, metastasis and poor responsiveness to CRT in ESCC patients.

AB - Background: Hypercoagulation has been reported to be associated with tumor progression and a poor prognosis in various carcinomas. In this study, we examined fibrinogen levels in pretreated patients with esophageal squamous cell carcinoma (ESCC) and assessed its correlation with clinicopathological factors and prognosis in patients with ESCC. Methods: Pretreatment fibrinogen levels were examined prior to surgery or other treatments (e.g. endoscopic mucosal resection and chemoradiotherapy [CRT]) in 105 patients with primary ESCC. We investigated the association of fibrinogen levels with clinicopathological background factors and the survival of ESCC patients. Results: The plasma fibrinogen concentration (PFC) ranged from 209.4 to 781.6 mg/dL. Pretreatment PFC correlated significantly with the depth of invasion (T factor). There also existed a significant correlation between higher fibrinogen levels and lymph node metastasis (N factor) and distant organ metastasis. Patients with a higher fibrinogen level experienced a significantly worse overall survival (P = 0.006). Fibrinogen levels strongly correlated with platelet counts, white blood cell counts and tumor length. Pretreatment PFC were observed to have a significant correlation with CRT responsiveness in ESCC patients in stages II and III (P = 0.005). Conclusion: This study revealed that higher levels of fibrinogen correlated with tumor progression, metastasis and poor responsiveness to CRT in ESCC patients.

KW - Chemoradiotherapy

KW - Esophageal cancer

KW - Fibrinogen

KW - Metastasis

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=36349029073&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36349029073&partnerID=8YFLogxK

U2 - 10.1111/j.1440-1746.2006.04736.x

DO - 10.1111/j.1440-1746.2006.04736.x

M3 - Article

C2 - 18031385

AN - SCOPUS:36349029073

VL - 22

SP - 2222

EP - 2227

JO - Journal of Gastroenterology and Hepatology (Australia)

JF - Journal of Gastroenterology and Hepatology (Australia)

SN - 0815-9319

IS - 12

ER -